See more : Toosla Société Anonyme (ALTOO.PA) Income Statement Analysis – Financial Results
Complete financial analysis of LifeQuest World Corporation (LQWC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LifeQuest World Corporation, a leading company in the Industrial – Pollution & Treatment Controls industry within the Industrials sector.
- Showa Sangyo Co., Ltd. (2004.T) Income Statement Analysis – Financial Results
- Agristar, Inc. (AGRS) Income Statement Analysis – Financial Results
- EC Healthcare (2138.HK) Income Statement Analysis – Financial Results
- Big Yellow Group Plc (BYG.L) Income Statement Analysis – Financial Results
- NEO Battery Materials Ltd. (NBMFF) Income Statement Analysis – Financial Results
LifeQuest World Corporation (LQWC)
Industry: Industrial - Pollution & Treatment Controls
Sector: Industrials
Website: https://lifequestcorp.com
About LifeQuest World Corporation
LifeQuest World Corporation, through its subsidiaries, provides effluent treatment and sewage treatment solutions. The company develops onsite sewage wastewater treatment system, which treats grey and black water that can be reused for irrigation, flushing, and cleaning. It also focuses on providing solutions for treatment of effluents in textile, tannery, fisheries, dairy, and processed water industries. The company offers Biopipe, a biological wastewater treatment system that could be used in detached houses, commercial and multi-family buildings, hotels, hospitals, industrial complexes, campgrounds, and parks; and Abrimix, a water treatment technology for treating wastewater, processed water, or raw water. In addition, it provides Glanris, a non-toxic filtration media for water filtration for municipalities, businesses, homeowners, and consumers; and Goslyn, a grease recovery device to remove fats, oils, and grease from wastewater effluent. The company was incorporated in 1997 and is based in Ridgefield Park, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 211.69K | 149.81K | 349.30K | 549.08K | 371.57K | 3.30K | 29.16K | 86.39K | 0.00 | 769.62K | 977.47K | 1.05M | 1.45M | 2.36M | 2.69M | 2.58M | 1.56M | 1.04M | 406.34K | 64.94K |
Cost of Revenue | 198.59K | 111.94K | 300.67K | 472.41K | 124.34K | 2.25K | 8.09K | 36.52K | 0.00 | 192.34K | 209.90K | 258.18K | 352.74K | 508.02K | 692.51K | 367.95K | 105.73K | 97.12K | 38.22K | 8.20K |
Gross Profit | 13.10K | 37.87K | 48.63K | 76.68K | 247.23K | 1.05K | 21.07K | 49.87K | 0.00 | 577.27K | 767.57K | 788.12K | 1.09M | 1.86M | 2.00M | 2.22M | 1.45M | 941.11K | 368.12K | 56.74K |
Gross Profit Ratio | 6.19% | 25.28% | 13.92% | 13.96% | 66.54% | 31.74% | 72.25% | 57.73% | 0.00% | 75.01% | 78.53% | 75.32% | 75.60% | 78.51% | 74.27% | 85.76% | 93.22% | 90.65% | 90.59% | 87.37% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 153.72K | 213.91K | 0.00 | 0.00 | 87.56K | 182.47K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 1.03K | 1.76K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 187.66K | 244.52K | 336.23K | 438.50K | 261.80K | -162.56K | -182.47K | 72.73K | 136.58K | 1.67M | 2.04M | 2.20M | 2.09M | 2.24M | 2.31M | 2.78M | 1.82M | 1.32M | 946.35K | 811.42K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 187.66K | 244.52K | 336.23K | 438.50K | 261.80K | -162.56K | -182.47K | 72.73K | 136.58K | 1.67M | 2.04M | 2.20M | 2.09M | 2.24M | 2.31M | 2.78M | 1.82M | 1.32M | 946.35K | 811.42K |
Cost & Expenses | 386.25K | 356.45K | 636.90K | 910.91K | 386.14K | -160.31K | -174.38K | 109.25K | 136.58K | 1.86M | 2.25M | 2.46M | 2.44M | 2.75M | 3.00M | 3.15M | 1.93M | 1.42M | 984.57K | 819.63K |
Interest Income | 20.00 | 82.00 | 288.00 | 467.00 | 354.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 4.64K | 92.82K | 66.23K | 6.00 | 125.00K | 129.58K | 182.64K | 93.92K | 95.06K | 125.35K | 97.64K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 67.77K | 62.81K | 42.34K | 15.03K | 11.84K | -88.61K | -203.54K | 22.82K | 0.00 | 5.33K | 7.37K | 9.63K | 12.19K | 12.75K | 8.54K | 7.50K | 29.00K | 29.01K | 28.65K | 6.78K |
EBITDA | -87.42K | -206.65K | -245.27K | -346.32K | -2.38K | 163.61K | 0.00 | -22.86K | -136.58K | -1.08M | -1.27M | -1.27M | -979.87K | -370.53K | -189.58K | -556.83K | -337.56K | -352.80K | -549.59K | -747.91K |
EBITDA Ratio | -41.30% | -137.94% | -70.22% | -63.16% | -0.73% | 4,954.88% | 698.06% | -1.16% | 0.00% | -124.07% | -129.63% | -147.11% | -67.84% | -15.67% | -11.32% | -21.76% | -21.37% | -33.65% | -135.84% | -1,156.41% |
Operating Income | -174.56K | -206.65K | -287.60K | -361.82K | -14.57K | 163.61K | 203.54K | -22.86K | -136.58K | 1.09M | 1.27M | 1.42M | 992.79K | 383.28K | 312.79K | 564.33K | 366.56K | 381.81K | 578.24K | 754.69K |
Operating Income Ratio | -82.46% | -137.94% | -82.34% | -65.90% | -3.92% | 4,954.88% | 698.06% | -26.46% | 0.00% | 141.60% | 130.38% | 135.28% | 68.69% | 16.21% | 11.62% | 21.84% | 23.51% | 36.77% | 142.31% | 1,162.19% |
Total Other Income/Expenses | 19.37K | -104.77K | -24.23K | 467.00 | -4.28K | -8.41M | -66.23K | -9.00 | -125.00K | -129.58K | -182.64K | 39.46K | -95.06K | -125.35K | -211.84K | 5.41K | -4.44K | -3.48K | 2.38K | 3.03K |
Income Before Tax | -155.19K | -311.41K | -311.83K | -361.36K | -18.85K | -8.25M | 137.31K | -22.87K | -261.58K | -1.22M | -1.46M | -1.38M | 0.00 | 0.00 | 313.27K | 569.74K | 362.12K | 378.33K | 580.62K | 757.72K |
Income Before Tax Ratio | -73.31% | -207.88% | -89.27% | -65.81% | -5.07% | -249,797.40% | 470.90% | -26.47% | 0.00% | -158.44% | -149.07% | -131.51% | 0.00% | 0.00% | 11.64% | 22.05% | 23.23% | 36.44% | 142.89% | 1,166.85% |
Income Tax Expense | 35.05K | 68.31K | -94.48K | 118.29K | 80.16K | 88.61K | 203.54K | -956.00 | 0.00 | 129.58K | -2.55M | -39.46K | 95.06K | 125.35K | 97.16K | -5.41K | 4.44K | 3.48K | -2.38K | -3.03K |
Net Income | -170.87K | -379.71K | -217.34K | -479.65K | -99.01K | -8.25M | 137.31K | -22.87K | -261.58K | -1.22M | -1.46M | -1.38M | -1.09M | -508.63K | -409.95K | -558.92K | -370.99K | -385.29K | -575.85K | -751.66K |
Net Income Ratio | -80.72% | -253.47% | -62.22% | -87.35% | -26.65% | -249,797.40% | 470.90% | -26.47% | 0.00% | -158.44% | -149.07% | -131.51% | -75.26% | -21.51% | -15.23% | -21.64% | -23.79% | -37.11% | -141.72% | -1,157.52% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.13 | 0.00 | -114.35K | -0.89 | 0.00 | -7.64 | -8.00 | -98.79 | -57.92 | -47.45 | -64.79 | -43.01 | -44.67 | -133.48 | -174.72 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.13 | 0.00 | -114.35K | -0.89 | 0.00 | -7.64 | -8.00 | -98.79 | -57.92 | -47.45 | -64.79 | -43.01 | -44.67 | -133.48 | -174.72 |
Weighted Avg Shares Out | 121.48M | 116.26M | 114.96M | 112.21M | 91.16M | 7.29M | 60.29M | 0.20 | 293.98K | 0.00 | 190.63K | 172.00K | 11.01K | 8.78K | 8.64K | 8.63K | 8.63K | 8.63K | 4.31K | 4.30K |
Weighted Avg Shares Out (Dil) | 121.48M | 116.23M | 114.96M | 112.21M | 91.16M | 7.29M | 60.29M | 0.20 | 293.98K | 0.00 | 190.63K | 172.00K | 11.01K | 8.78K | 8.64K | 8.63K | 8.63K | 8.63K | 4.31K | 4.30K |
LifeQuest's Wholly Owned Subsidiary Receives an Order for a 30m3/Day (7,900 Gallons/Day) Sewage Wastewater Treatment Plant From a Hospital in India
Lifequest Subsidiary Completes the First Commercial Sale in Ethiopia of a 100m3/Day Capacity Biopipe Sewage Wastewater Treatment Plant
Source: https://incomestatements.info
Category: Stock Reports